Growing Prevalence of Tooth Loss, Increasing Dental Implant Procedures, And Rising Patient Preference for Regenerative Treatments Are Transforming the U.S. Dental Bone Graft Market

The U.S. dental bone graft market is experiencing robust growth driven by the rising prevalence of periodontal diseases, increasing incidence of tooth loss, and a steady surge in dental implant procedures across the country. Growing awareness about advanced restorative and regenerative dental solutions has elevated the strategic importance of bone grafting materials in enabling successful implant placement and long-term oral rehabilitation outcomes. The expanding geriatric population—more susceptible to edentulism and bone resorption—continues to fuel demand for reliable grafting solutions that enhance bone volume, density, and structural stability.

Access Full Report @ http://databridgemarketresearch.com/reports/us-dental-bone-graft-market

Data Bridge market research analyzes that the U.S. Dental Bone Graft Market is expected to reach USD 1,092.07 million by 2033 from USD 408.60 million in 2025, growing at a substantial CAGR of 13.8% in the forecast period of 2026 to 2033.

Key Findings of the Study

Sustained Increase in Implant-Driven Bone Augmentation Procedures Across the U.S.

The steady expansion of implant dentistry across the U.S. has been accompanied by a parallel rise in bone augmentation procedures. In routine clinical practice, it has been observed that a considerable proportion of implant candidates present with insufficient alveolar bone volume at the time of consultation. Bone resorption following long-term tooth loss, untreated periodontal conditions, or trauma has made preparatory grafting an increasingly common step rather than an exception. Ridge preservation at the time of extraction and staged augmentation prior to implant placement are now being incorporated into standard treatment planning across specialty practices and advanced general dentistry settings throughout the U.S. Across metropolitan and suburban markets in the U.S., implant therapy has gradually shifted from being viewed as a premium restorative option to becoming a mainstream solution for long-term tooth replacement. With growing patient awareness regarding durability, functionality, and aesthetics, demand for implant-supported restorations has continued to strengthen. As a result, bone grafting procedures such as sinus lifts, horizontal ridge augmentation, and socket preservation have been performed with greater frequency to ensure implant stability and long-term success. This structural integration of augmentation into implant workflows has contributed to consistent material utilization in surgical practices across the country.

Report Scope and Market Segmentation

Segment Analysis

The U.S. Dental Bone Graft market is segmented into ten notable segments which are based on product, brand, application, usage, mechanism, material form, age, population type, end user, and distribution channel.

• On the basis of Offering, the U.S. Dental Bone Graft market is segmented into Hardware, Services, and Software.

In 2026, the Natural Bone Graft segment is expected to dominate the market

• On the basis of product, the U.S. Dental Bone Graft market is segmented into Synthetic Bone Graft, Natural Bone Graft, Live Osteogenic Cells Bone Substitutes, Growth Factors, and Others. In 2026, the Hardware segment is expected to dominate with 54.51% market share.

In 2026, the Bio OSS segment is expected to dominate the market

• On the basis of brand, the Dental Bone Graft market is segmented into Bio-Oss, Grafton, Cerabone, Perioglas, Endobon, Osteograf, Mastergraft, and Others. In 2026, the Bio OSS segment is expected to dominate the market with 15.04% market share.

In 2026, the Implant Bone Regeneration Size segment is expected to dominate the market

• On the basis of application, the Dental Bone Graft market is segmented into Socket Preservation, Ridge Augmentation, Periodontal Defect Regeneration, Implant Bone Regeneration, Sinus Lift, and Others. In 2026, the Implant Bone Regeneration Size segment is expected to dominate the market with 28.95% market.

In 2026, the Bone Graft Substitutes segment is expected to dominate the market

• On the basis of usage, the Dental Bone Graft market is segmented into S Bone Graft Substitutes and Bone Graft Extenders. In 2026, the Standalone UPS segment is expected to dominate the market with 76.91% market share.

In 2026, the Osteoconduction segment is expected to dominate the market

• On the basis of mechanism, the Dental Bone Graft market is segmented into Osteoconduction, Osteoinduction, Osteopromotion, and Osteogenesis. In 2026, the Backup Power segment is expected to dominate the market with 76.22% market share.

In 2026, the Granules segment is expected to dominate the market

• On the basis of material form, the Dental Bone Graft market is segmented into Injectables, Granules, and Putty. In 2026, the Three Phase segment is expected to dominate the market with 44.26% market share.

In 2026, the Adult segment is expected to dominate the market

• On the basis of basis of age, the Dental Bone Graft market is segmented into Pediatrics, Adult, and Geriatric. In 2026, the adult segment is expected to dominate the market with 60.00% market share.

In 2026, the Female segment is expected to dominate the market

• On the basis of population type, the Dental Bone Graft market is segmented into Male and Female. In 2026, the Female segment is expected to dominate the market with 53.82% market share.

In 2026, the Dental Clinics segment is expected to dominate the market

• On the basis of end user, the Dental Bone Graft market is segmented into Hospitals, Dental Clinics, Research and Dental Laboratories, and Others. In 2026, the Dental Clinics segment is expected to dominate the market with 72.18% market share.

In 2026, the Direct Tender segment is expected to dominate the market

• On the basis of distribution channel, the Dental Bone Graft market is segmented into Direct Tender, Third Party Distributors, and Others. In 2026, the Direct Tender segment is expected to dominate the market with 59.03% market share.

Major Players

Geistlich Pharma AG (Switzerland), Botiss Biomaterials GmbH (Germany), ZimVie Inc. (U.S.), Dentsply Sirona (Symbios) (U.S.), Nobel Biocare (Envista) (Switzerland), BioHorizons Camlog (Switzerland), Osstem Implant Co., Ltd. (South Korea), Dentium (South Korea), Mega’Gen Implant Co., Ltd. (South Korea), Purgo Biologics Inc. (U.S.), Regenity Biosciences (U.S.), NovaBone (U.S.), Impladent Ltd. (U.S.), Curasan AG (Germany), LifeNet Health (U.S.), MTF Biologics (U.S.), Evergen (formerly RTI Surgical) (U.S.), SigmaGraft Biomaterials (U.S.), Augma Biomaterials Ltd. (United Kingdom), Keystone Dental Group (U.S.), Orthogen, LLC (U.S.)

Market Developments

• In July 2025, ZimVie Inc. entered into an exclusive distribution agreement with Osstem Implant Co., Ltd. to expand its premium dental implant portfolio in China. Under the agreement, Osstem assumes exclusive commercial responsibility for ZimVie’s implant systems in the Chinese market, leveraging its extensive distribution network and strong presence across more than 90 cities. This development is intended to strengthen ZimVie’s global footprint, improve customer access to its precision-engineered implant solutions, and capitalize on the rapidly growing Chinese dental implant market.
• In July 2024, Dentsply Sirona announced the renewal and enhancement of its Symbios allograft product line, emphasizing improved sterility standards and clinical versatility. The updated portfolio introduces advanced granule and putty bone graft formats designed to support predictable bone regeneration across a wide range of dental and implant procedures. The refreshed products are manufactured under stringent safety protocols and offered in multiple granule sizes and configurations to enhance handling and clinical performance. This development reinforces the company’s commitment to delivering high-quality regenerative solutions that improve surgical outcomes and procedural flexibility.
• In January 2026, Zircon Medical Equipment LLC signed a strategic partnership agreement with DENTIUM at AEEDC Dubai 2026 to expand access to Dentium’s advanced dental implant systems and digital dentistry solutions across the United Arab Emirates. The collaboration leverages Dentium’s global expertise and Zircon’s regional distribution strength to enhance clinical care, support innovation, and elevate standards in the UAE’s dental sector, helping DENTIUM grow its presence and influence in the region.
• In February, Evergen announced the launch of new AI-powered image processing software to advance the analysis of CT bone graft scans. The software has been under development for two years, in partnership with the Department of Mechanical and Aerospace Engineering at the University of Florida (UF). The new technology streamlines tissue processing by analyzing data from CT scans of human bone grafts, ensuring accurate decision-making based on quantitative data.
• In December, RTI Surgical unveiled its new corporate identity as Evergen, signaling its strategic evolution into a premier contract development and manufacturing organization (CDMO) providing biosolutions in regenerative medicine.

For more detailed information about the U.S. Dental Bone Graft Market report, click here – http://databridgemarketresearch.com/reports/us-dental-bone-graft-market